Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
BJGP Open ; 5(6)2021.
Artículo en Inglés | MEDLINE | ID: mdl-34475020

RESUMEN

BACKGROUND: Medical graduates from the universities of Oxford and Cambridge have a lower intention to become GPs compared with other UK medical graduates. It is not clear to what extent this difference is present on admission to medical school. AIM: To compare the career intention and influencing factors of students on admission to different UK medical schools. DESIGN & SETTING: First year of a 6-year prospective cohort study of medical students admitted in autumn 2020 to the three East of England medical schools: University of East Anglia (UEA), University of Cambridge (UOC), and Anglia Ruskin University (ARU). METHOD: An online survey instrument was administered at the beginning of the first year. This measured self-reported career interests and various influencing factors, including perceptions of general practice. RESULTS: UOC students declared a lower intention to become a doctor, a higher likelihood of choosing careers in pathology and public health, and a much lower likelihood of becoming a GP than students of UEA or ARU (all at P<0.001). In all three schools, the phrases least associated with general practice were 'opportunities for creativity/innovation' and 'research/academic opportunities', whereas the phrases most associated with general practice were 'favourable working hours' and 'flexibility'. However, research/academic opportunities were far more important, and favourable working hours far less important, to UOC students (P<0.001 for both) than to students of UEA or ARU. CONCLUSION: UOC students' lower intention to become a GP appears to be present on entry to medical school. This may be explained in part by these students placing a higher importance on research/academic opportunities, combined with the widely held perception that GP careers lack these opportunities.

2.
Australas J Dermatol ; 50(3): 207-10, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19659985

RESUMEN

Worldwide, proton pump inhibitors (PPI) are one of the most frequently prescribed drugs; however, up to 70% of patients taking these drugs have no appropriate indication. Although PPI are relatively well tolerated, they are not free from side-effects and several life-threatening complications are associated with them. In the present report, a 43-year-old woman presented to her general practitioner with an erythematous rash over her face and chest, having been started on omeprazole for chronic abdominal bloating. Over the next 24 h she became increasingly unwell and was admitted to hospital with shortness of breath, pyrexia and the rash spreading over her back, arms and legs. Vesicles had now started to appear within the erythematous regions over her upper body and within 24 h the rash became confluent and desquamative, spreading to involve her entire body. A diagnosis of toxic epidermal necrolysis (TEN) was made. Despite supportive treatment within a critical care setting, she became neutropaenic and her skin loss became more extensive, resulting in 95% epidermal detachment. This case highlights that TEN is a life-threatening condition associated with a high incidence of morbidity and mortality. Optimal management requires early diagnosis and transfer to a specialized unit. Clinicians need to be aware that PPI are not free from side-effects and that their routine prescription should be strongly discouraged.


Asunto(s)
Dispepsia/tratamiento farmacológico , Omeprazol/efectos adversos , Inhibidores de la Bomba de Protones/efectos adversos , Síndrome de Stevens-Johnson/etiología , Síndrome de Stevens-Johnson/terapia , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/terapia , Adulto , Biopsia con Aguja , Terapia Combinada , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Progresión de la Enfermedad , Dispepsia/diagnóstico , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Insulina/uso terapéutico , Omeprazol/uso terapéutico , Inhibidores de la Bomba de Protones/uso terapéutico , Diálisis Renal , Medición de Riesgo , Síndrome de Stevens-Johnson/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...